Marcelle Altshuler just received 3rd prize in the HHMI Science for Life Creativity in Arts and Sciences poster presentation for her work on “Developing Neurons are sensitive to TDP-43 Induction”. There were ~130 participants, with only 20 prizes awarded. This award will provide Marcelle with travel funding to attend the…
Continuing the CTRND’s tradition of research excellence, Dr. Naruhiko Sahara has been honored as a recipient of a 2012 Thomas H Maren Junior Investigator award. Dr. Sahara’s research explores the underlying mechanisms of Alzheimer’s disease and related neurodegenerative disorders, focusing on protein biochemistry and neurochemistry. Specifically, Dr. Sahara is investigating…
We are pleased to announce the arrival of Dr. Benoit Giasson as a new member of the CTRND faculty.
In an article published in the September 2011 edition of The Journal of Neuropathology and Experimental Neurology senior author Dr. Naruhiko Sahara along with contributors from the Mayo Clinic Jacksonville reported that very little caspase-cleaved tau existed in tauopathy mouse model. Our finding suggests that caspase activation might be one…
We are pleased to announce the arrival of Dr. Kevin Felsenstein, Ph.D. as a new member of the CTRND faculty. Dr. Felsenstein brings over 20 years of research in the pharmaceutical/biotech industry where he specialized in the small molecule drug discovery covering anti-infectives and neuroscience.
In a study published in the May 15th online issue of Nature Neuroscience first author Paramita Chakrabarty and senior author Todd Golde of the University of Florida in Gainesville along with other contributors form University of Florida and Mayo Clinic Florida, describe a novel mouse model …
We are pleased to announce the arrival of Jada Lewis, PhD and Nikolaus McFarland, MD, PhD as new faculty within the CTRND. Dr. McFarland comes to University of Florida from Massachusetts General Hospital-Harvard Medical School where his research focused on Parkinson disease and related synucleinopathies, employing both cellular and targeted…
